The long-running “Du More” motif for Sanofi and Regeneron’s immunology blockbuster Dupixent is looking to make a splash with its first new commercial of 2023. In the 60-second spot, “It's Possible: ...

Dupixent topped Rx and over-the-counter (OTC) pharma brands for ad impressions during Q1 2025, according to data released by iSpot.tv on Monday afternoon. The Regeneron and Sanofi brand for asthma and ...

The first half of the top monthly Rx and over-the-counter (OTC) pharma brands in May looks a lot like it did in April. The rankings are identical, actually. For the second consecutive month, Dupixent ...

While non-response to Dupixent is uncommon, atopic dermatitis (AD) patients who are refractory lack safe and effective treatments according to REACH Market Research. NEWTON, Mass., July 26, 2023 ...